Weekly Recap | Dolby Laboratories +1.58%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.Dolby Laboratories (DLB) added 1.58% this week to close at $58.56, outpacing the S&P 500 by about 0.37 percentage points. Trading was choppy: the stock opened lower on Monday, dipping to $56.87 before recovering, then pushed to an intraday high of $59.97 on Wednesday and pulled back over the next two sessions. Weekly amplitude was 6.18% on volume of about 5.2 million shares. There was no major company-specific catalyst, and the price action largely tracked the broader market.
The Week
Dolby Laboratories (DLB) added 1.58% this week to close at $58.56, outpacing the S&P 500 by about 0.37 percentage points. Trading was choppy: the stock opened lower on Monday, dipping to $56.87 before recovering, then pushed to an intraday high of $59.97 on Wednesday and pulled back over the next two sessions. Weekly amplitude was 6.18% on volume of about 5.2 million shares. There was no major company-specific catalyst, and the price action largely tracked the broader market.
Analyst Ratings
Four brokers cover the stock: two rate it buy, one overweight and one hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of $79, roughly 34.9% above the current price. Targets range from $62 to $90, a wide spread that points to lingering disagreement about the valuation. Within systems software, Dolby’s rating rank is 35th out of 46 names, in the lower half of the sector.
The Week Ahead
The US macro calendar is busy next week: the Dallas Fed manufacturing index on 28 September, followed on 29 September by FHFA house prices, the Case Shiller 20-city index, JOLTS job openings and consumer confidence. Dolby’s own earnings are not yet in the window, but rate-sensitive tech sentiment could react to these data points. The stock’s next fundamental update remains the key longer-term focus.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
